Clinical outcome of initially unresectable pancreatic cancer patients: Conversion surgery after modified FOLFIRINOX or gemcitabine nab-paclitaxel

被引：0
|
作者：
Ushida, Yuta [1 ]
Inoue, Yosuke [1 ]
Ito, Hiromichi [1 ]
Ono, Yoshihiro [1 ]
Sato, Takafumi [1 ]
Takahashi, Yu [1 ]
机构：
[1] Japanese Fdn Canc Res, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
725
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study
    Williet, Nicolas
    Petrillo, Angelica
    Roth, Gael
    Ghidini, Michele
    Petrova, Mila
    Forestier, Julien
    Lopez, Anthony
    Thoor, Audrey
    Weislinger, Lucie
    De Vita, Ferdinando
    Taieb, Julien
    Phelip, Jean Marc
    CANCERS, 2021, 13 (11)
  • [42] FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational study
    Servetto, Alberto
    Santaniello, Antonio
    Napolitano, Fabiana
    Foschini, Francesca
    Marciano, Roberta
    Cascetta, Priscilla
    Amato, Anna Rita
    Augurio, Maria Rosaria
    Maresca, Lucia
    De Placido, Pietro
    De Placido, Sabino
    Formisano, Luigi
    Bianco, Roberto
    FUTURE ONCOLOGY, 2022, 18 (21) : 2643 - 2654
  • [43] NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer
    Nichetti, Federico
    Rota, Simone
    Ambrosini, Paolo
    Pircher, Chiara
    Gusmaroli, Eleonora
    Busset, Michele Droz Dit
    Pusceddu, Sara
    Sposito, Carlo
    Coppa, Jorgelina
    Morano, Federica
    Pietrantonio, Filippo
    Di Bartolomeo, Maria
    Mariani, Luigi
    Mazzaferro, Vincenzo
    de Braud, Filippo
    Niger, Monica
    JAMA NETWORK OPEN, 2024, 7 (01)
  • [44] Sequence Therapy with FOLFIRINOX and Gemcitabine/Nab-Paclitaxel for Patients with Advanced Pancreatic Cancer: A Monocentre Retrospective Cohort Study
    Queck, Alexander
    Elango, Sharra
    Koch, Christine
    Walter, Dirk
    Schmidt, Jennifer
    Trebicka, Jonel
    Trojan, Joerg
    Pession, Ursula
    Finkelmeier, Fabian
    Waidmann, Oliver
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (03) : 79 - 86
  • [45] Impact of Statin Use on Survival in Patients With Unresectable Pancreatic cancer Receiving Gemcitabine Plus Nab-Paclitaxel
    Saito, Kei
    Nakai, Yousuke
    Sasaki, Takashi
    Takeda, Tsuyoshi
    Ueno, Makoto
    Tezuka, Shun
    Isayama, Hiroyuki
    Tomishima, Ko
    Kojima, Yasushi
    Yamamoto, Natsuyo
    Ito, Yukiko
    Oyama, Hiroki
    Toda, Nobuo
    Takagi, Kaoru
    Matsubara, Saburo
    Mohri, Dai
    Sato, Tatsuya
    Fujishiro, Mitsuhiro
    PANCREAS, 2025, 54 (02) : e107 - e113
  • [46] Pilot trial of gemcitabine, nab-paclitaxel, metformin, and a standardized dietary supplement in patients with unresectable pancreatic cancer
    Chung, Vincent
    Frankel, Paul
    Shibata, Stephen
    Mambetsariev, Isa
    Yin, Holly
    Mirzapoiazova, Tamara
    Mambetsariev, Bolot
    Kulkarni, Prakash
    Lim, Dean
    Li, Daneng
    Chao, Joseph
    Fakih, Marwan
    Bild, Andrea
    Pillai, Raju
    Adalsteinsson, Orn
    Hirsh, Steven
    Salgia, Ravi
    CANCER RESEARCH, 2019, 79 (24)
  • [47] Second-line treatment of modified FOLFIRINOX or nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma
    Ozaka, Masato
    Sasaki, Takashi
    Yamada, Ikuhiro
    Kanata, Ryo
    Akiyama, Dai
    Katagiri, Tomoko
    Takano, Koichi
    Matsuyama, Masato
    Sasahira, Naoki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [48] FOLFIRINOX versus gemcitabine nab-paclitaxel for advanced pancreatic cancer: KU Cancer Center experience.
    Kasi, Anup
    Middinti, Akshay
    Cao, An
    Vekaria, Pratikkumar
    Patel, Devangi
    Subramaniam, Dipti
    Chen, Guoqing J.
    Saeed, Anwaar Mohammed
    Paluri, Ravi Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer
    Sawada, Masashi
    Kasuga, Akiyoshi
    Mie, Takafumi
    Furukawa, Takaaki
    Taniguchi, Takanobu
    Fukuda, Koshiro
    Yamada, Yuto
    Takeda, Tsuyoshi
    Kanata, Ryo
    Matsuyama, Masato
    Sasaki, Takashi
    Ozaka, Masato
    Sasahira, Naoki
    BMC CANCER, 2020, 20 (01)
  • [50] Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer
    Masashi Sawada
    Akiyoshi Kasuga
    Takafumi Mie
    Takaaki Furukawa
    Takanobu Taniguchi
    Koshiro Fukuda
    Yuto Yamada
    Tsuyoshi Takeda
    Ryo Kanata
    Masato Matsuyama
    Takashi Sasaki
    Masato Ozaka
    Naoki Sasahira
    BMC Cancer, 20
12345